Rice Hall James & Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-82,110
| Closed | -$12.4M | – | 276 |
|
|
2022
Q3 | $12.4M | Sell |
82,110
-180,920
| -69% | -$27.4M | 0.72% | 43 |
|
|
2022
Q2 | $38.3M | Sell |
263,030
-13,976
| -5% | -$2.04M | 1.85% | 13 |
|
|
2022
Q1 | $32.8M | Sell |
277,006
-4,945
| -2% | -$586K | 1.31% | 19 |
|
|
2021
Q4 | $38.9M | Sell |
281,951
-1,799
| -0.6% | -$248K | 1.38% | 19 |
|
|
2021
Q3 | $39.4M | Sell |
283,750
-7,111
| -2% | -$988K | 1.46% | 19 |
|
|
2021
Q2 | $28.2M | Buy |
290,861
+26,303
| +10% | +$2.55M | 1% | 31 |
|
|
2021
Q1 | $18.1M | Buy |
+264,558
| New | +$18.1M | 0.59% | 51 |
|